FDA DrugClass IINotable

FDA Recall: 0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex

Date: 2026-04-15
Brand: Fresenius Kabi USA, LLC
Category: Drug
FDA Class: Class II

Description

Lack of Assurance of Sterility

Hazard

Lack of Assurance of Sterility

View original recall →
Share:

Related Recalls

2026-04-15 · FDA_DRUG
FDA Recall: 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freef
Fresenius Kabi USA, LLC
2026-04-15 · FDA_DRUG
FDA Recall: 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freefle
Fresenius Kabi USA, LLC
2026-04-15 · FDA_DRUG
FDA Recall: 0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Frankl
Fresenius Kabi USA, LLC
2026-04-15 · FDA_DRUG
FDA Recall: 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freefle
Fresenius Kabi USA, LLC